ACP
CEMI

Acuta Capital Partners’s Chembio diagnostics, Inc. CEMI Stock Holding History

Acuta Capital Partners’s Portfolio CEMI Stock Details CEMI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-41,667
Closed -$255K – 52
2019
Q3 		$255K Hold
41,667
– – 0.18% 31
2019
Q2 		$254K Hold
41,667
– – 0.09% 30
2019
Q1 		$231K Sell
41,667
-345,500
-89% -$2.24M 0.11% 31
2018
Q4 		$2.19M Sell
387,167
-1,643,366
-81% -$12.1M 1.67% 16
2018
Q3 		$21.3M Hold
2,030,533
– – 7.61% 5
2018
Q2 		$22.5M Buy
2,030,533
+23,866
+1% +$215K 4.01% 7
2018
Q1 		$16.1M Buy
2,006,667
+285,368
+17% +$2.28M 2.62% 12
2017
Q4 		$14.1M Hold
1,721,299
– – 2.66% 12
2017
Q3 		$10.7M Buy
1,721,299
+362,948
+27% +$2.23M 1.91% 12
2017
Q2 		$8.22M Buy
1,358,351
+156,207
+13% +$976K 2.3% 11
2017
Q1 		$6.37M Buy
1,202,144
+51,219
+4% +$298K 1.51% 17
2016
Q4 		$7.83M Buy
1,150,925
+379,249
+49% +$2.63M 2.91% 13
2016
Q3 		$5.71M Buy
771,676
+759,496
+6,236% +$5.47M 2.14% 16
2016
Q2 		$100K Buy
+12,180
New +$94.9K 0.05% 62
2015
Q3 		– Sell
-130,000
Closed -$638K – 75
2015
Q2 		$638K Sell
130,000
-16,099
-11% -$74.4K 0.39% 42
2015
Q1 		$590K Hold
146,099
– – 0.5% 40
2014
Q4 		$571K Buy
+146,099
New +$605K 0.39% 54

Other funds holding CEMI

NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $15.3B AUM 40.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $8.43B AUM 52.02% 1-Year Est. Return
AIP
ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
GA
Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Acuta Capital Partners's CEMI Position: Q4 2019 in Review

Acuta Capital Partners sold out of Chembio diagnostics, Inc. (CEMI) in Q4 2019, closing a stake of 41,667 shares — an estimated $255K sold.

Acuta Capital Partners first reported a position in CEMI in Q4 2014 and held it in 17 quarters. The position peaked at $22.5M in Q2 2018. 39 funds tracked by Wall St. Rank hold CEMI as of Q4 2019.

  • Acuta Capital Partners reported no remaining Chembio diagnostics, Inc. position as of Q4 2019 after selling out during the quarter.
  • Acuta Capital Partners sold 41,667 Chembio diagnostics, Inc. shares in Q4 2019, an estimated $255K.
  • Acuta Capital Partners first reported a position in Chembio diagnostics, Inc. in Q4 2014 and held it in 17 quarters.
  • Acuta Capital Partners's Chembio diagnostics, Inc. position peaked at $22.5M in Q2 2018.
  • 39 funds tracked by Wall St. Rank held Chembio diagnostics, Inc. as of Q4 2019.

Based on Acuta Capital Partners's 13F filing for Q4 2019, filed 14 Feb 2020.